Oligonucleotide based nanogels for cancer therapeutics

Area of Science:

• Biomaterials Science
• Nanotechnology
• Oncology

Background:

• Oligonucleotide-based nanogels are emerging biomaterials with unique functional, structural, and physicochemical properties.
• These nanoplatforms offer high potential for cancer gene therapy due to their excellent drug-loading capacity and tunable characteristics.

Purpose of the Study:

• To summarize the properties, preparation methods, and applications of oligonucleotide-based nanogels in cancer therapy.
• To review both conventional and modified nanogel forms, including targeted and stimuli-responsive systems.

Main Methods:

• Review of existing literature on oligonucleotide-based nanogels.
• Focus on self-assembly or chemical crosslinking for nanogel development.
• Discussion of various nanogel modifications and applications.

Main Results:

• Oligonucleotide-based nanogels can be precisely engineered for predictable shape, tunable size, and desired functionalities.
• Applications span gene delivery, cancer immunotherapy, vaccination, photodynamic therapy, and diagnostics.
• Modified nanogels include targeted and smart-release systems responsive to stimuli like pH, temperature, and enzymes.

Conclusions:

• Oligonucleotide-based nanogels represent a versatile nano-vehicle with significant promise in cancer therapy.
• The field is nascent, and clinical translation requires extensive research into in vivo behavior, biodistribution, biological fate, and toxicity.